Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Cash from Operations (2016 - 2026)

Intellia Therapeutics has reported Cash from Operations over the past 12 years, most recently at 117346000.0 for Q1 2026.

  • Quarterly Cash from Operations rose 21.21% to 117346000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 363152000.0 through Mar 2026, up 3.71% year-over-year, with the annual reading at 394736000.0 for FY2025, 13.14% down from the prior year.
  • Cash from Operations was 117346000.0 for Q1 2026 at Intellia Therapeutics, down from 69285000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 58186000.0 in Q2 2024 and troughed at 148930000.0 in Q1 2025.
  • The 5-year median for Cash from Operations is 89869000.0 (2022), against an average of 93431470.59.
  • Year-over-year, Cash from Operations soared 35.58% in 2024 and then plummeted 71.21% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 89869000.0 in 2022, then fell by 3.54% to 93054000.0 in 2023, then increased by 8.45% to 85195000.0 in 2024, then grew by 18.67% to 69285000.0 in 2025, then plummeted by 69.37% to 117346000.0 in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Cash from Operations are 117346000.0 (Q1 2026), 69285000.0 (Q4 2025), and 76899000.0 (Q3 2025).